PREVENTION OF CHOLELITHIASIS

Download full text PDF
Issue: 
10
Year: 
2016

Yu. Tonkikh, Candidate of Medical Sciences; Professor V. Chukanov, MD; A. Vasyutin, Candidate of Medical Sciences; E. Bronnikov, Candidate of Biological Sciences Research Institute of Medical Problems of the North, Krasnoyarsk

The paper gives evidence for the expediency and efficiency of preventing cholelithiasis, the important methods of which are to increase physical activity, to lose weight, and to modify a diet. It provides a rationale for using ursodeoxycholic acid in the risk group to prevent cholelithiasis.

Keywords: 
gastroenterology
guideline
prevention
cholelithiasis



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones // J. Hepatol. – 2016; 65 (1): 146–81.
  2. Tonkih Ju.L., Bronnikova E.P., Tsukanov V.V. Rasprostranennost' i fak tory riska zabolevanij zhelchevyvodjaschih putej u korennyh zhitelej Tyvy // Zdravoohranenie Rossijskoj Federatsii. – 2014; 58 (5): 42–5.
  3. Ageeva E.S., Shtygasheva O.V., Tsukanov V.V. i dr. Immunologicheskie oso bennosti techenija gastroduodenal'noj patologii u zhitelej Hakasii // Immunologija. – 2009; 30 (3): 162–4.
  4. Tsukanov V.V., Kupershtejn E.Ju., Tonkih Ju.L. i dr. Assotsiatsija zhirno kislotnogo sostava syvorotki krovi s lipidnym sostavom zhelchi u bol'nyh holelitiazom // Ter. arh. – 2008; 80 (2): 71–5.
  5. Tsukanov V.V., Kupershtejn E.Ju., Tonkih Ju.L. i dr. Spektr zhirnyh kislot i lipidov syvorotki krovi u bol'nyh holelitiazom // Klin. medi-tsina. – 2009; 87 (2): 42–4.
  6. Chen L., Qiao Q., Zhang S. et al. Metabolicsyndrome and gallstone disease // World J.Gastroenterol. – 2012; 18: 4215–20.
  7. Stender S., Nordestgaard B., Tybjaerg-Hansen A. Elevated body mass indexas a causal risk factor for symptomatic gallstone disease: a mendelianrandomization study // Hepatology. – 2013; 58: 2133–41.
  8. Kriska A., Brach J., Jarvis B. et al. Physical activity and gallbladder disease determined by ultrasonography // Med. Sci. Sports Exerc. – 2007; 39: 1927–32.
  9. Banim P., Luben R., Wareham N. et al. Physical activity reduces the risk of symptomatic gallstones: a prospective cohort study // Eur. J. Gastroenterol. Hepatol. – 2010; 22: 983–8.
  10. Lukicheva E., Tonkikh J., Kasparov E. et al. Lipid composition of bile, motor functions of the gallbladder and prevalence of biliary diseases in native inhabitants and new comers of Evenkia // Dal'nevostochnyj meditsinskij zhurnal. – 2011; 4: 23–6
  11. Butorin N.N., Bichurina T.B., Tsukanov V.V. i dr. Rasprostranennost' i klinicheskie aspekty pischevoda Barretta u naselenija Vostochnoj Sibiri // Ter. arh. – 2013; 85 (1): 62–5.
  12. Tsukanov V.V., Tret'jakova O.V., Amel'chugova O.S. i dr. Rasprostranennost' atroficheskogo gastrita tela zheludka u naselenija g. Krasnojarska starshe 45 let // Ros. zhurn. gastroenterol., gepatol., koloproktol. – 2012; 22 (4): 27–31.
  13. Mendez-Sanchez N., Zamora-Valdes D., Chavez-Tapia N. et al. Role of diet in cholesterol gallstone formation // Clin. Chim. Acta. – 2007; 376: 1–8.
  14. Johansson K., Sundstrom J., Marcus C. et al. Risk ofsymptomatic 14. gallstones and cholecystectomy after a very-low-calorie dietor low-calorie diet in a commercial weight loss program: 1-year matchedcohort study // Int. J. Obes. – 2014; 38: 279–84.
  15. Festi D., Villanova N., Colecchia A. Risk factors for gallstone formation 15. during weight loss // Clin. Gastroenterol. Hepatol. – 2015; 13: 613.
  16. Stokes C., Gluud L., Casper M. et al. Ursodeoxycholic acid and diets higher 16. in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials // Clin. Gastroenterol. Hepatol. – 2014; 12: 1090–100.
  17. Sugerman H., Brewer W., Shiffman M. et al. A multicenter, placebo- controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss // Am. J. Surg. – 1995; 169: 91–6.
  18. Attanasio R., Mainolfi A., Grimaldi F. et al. Somatostatin analogs and gallstones: a retrospective survey on a largeseries of acromegalic patients // J. Endocrinol. Invest. – 2008; 31: 704–10.
  19. Venneman N., van Erpecum K. Gallstone disease: primary and secondaryprevention // Best Pract. Res. Clin. Gastroenterol. – 2006; 20: 1063–73.
  20. Marjoribanks J., Farquhar C., Roberts H. et al. Long term hormone 20. therapy for perimenopausal and postmenopausal women // Cochrane Database Syst. Rev. – 2012; 7: CD004143